These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 25451955)

  • 1. Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.
    Guadagno PA; Summers Bellin EG; Harris WS; Dayspring TD; Hoefner DM; Thiselton DL; Stanovick B; Warnick GR; McConnell JP
    Clin Chim Acta; 2015 Jan; 439():219-24. PubMed ID: 25451955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
    Konerman M; Kulkarni K; Toth PP; Jones SR
    J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms.
    Contois JH; Nguyen RA; Albert AL
    Clin Chim Acta; 2020 Jun; 505():119-124. PubMed ID: 32113814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method.
    Baudhuin LM; Hartman SJ; O'Brien JF; Meissner I; Galen RS; Ward JN; Hogen SM; Branum EL; McConnell JP
    Clin Biochem; 2004 Jun; 37(6):481-8. PubMed ID: 15183296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of cholesterol in lipoprotein fractions by agarose gel electrophoresis].
    Yan SK; Ren FQ; Song YH; Lin QS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):93-6. PubMed ID: 12905830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size.
    Tsimikas S; Fazio S; Viney NJ; Xia S; Witztum JL; Marcovina SM
    J Clin Lipidol; 2018; 12(5):1313-1323. PubMed ID: 30100157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory validation of a low density lipoprotein apolipoprotein-B assay.
    Kelsey DE; Toher JL; Foster MT; Boulanger JA; Cervinski MA
    Clin Biochem; 2014 Nov; 47(16-17):211-5. PubMed ID: 25079242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophoresis and the traditional method for the measurement of lipoprotein cholesterol in serum].
    Wang JG; Xie XS
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):51-4. PubMed ID: 12575236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein(a) as a cardiovascular risk factor].
    van Lennep JE; Mulder MT
    Ned Tijdschr Geneeskd; 2011; 155(42):A3582. PubMed ID: 22027461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a)-cholesterol: a significant component of serum cholesterol.
    Kinpara K; Okada H; Yoneyama A; Okubo M; Murase T
    Clin Chim Acta; 2011 Sep; 412(19-20):1783-7. PubMed ID: 21672532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofixation electrophoresis (IFE) of serum apolipoproteins: a new tool for probing lipoprotein disorders and the atherosclerosis risk.
    Semprini A; Maddalena-Feruzzi A; Giunta S
    Arch Gerontol Geriatr; 1992; 15 Suppl 1():325-32. PubMed ID: 18647703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) mass: a massively misunderstood metric.
    McConnell JP; Guadagno PA; Dayspring TD; Hoefner DM; Thiselton DL; Warnick GR; Harris WS
    J Clin Lipidol; 2014; 8(6):550-553. PubMed ID: 25499936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.